ATE307340T1 - Verfahren für die feststellung von asthma suszeptibilität - Google Patents

Verfahren für die feststellung von asthma suszeptibilität

Info

Publication number
ATE307340T1
ATE307340T1 AT99968477T AT99968477T ATE307340T1 AT E307340 T1 ATE307340 T1 AT E307340T1 AT 99968477 T AT99968477 T AT 99968477T AT 99968477 T AT99968477 T AT 99968477T AT E307340 T1 ATE307340 T1 AT E307340T1
Authority
AT
Austria
Prior art keywords
asthma
asthma susceptibility
severity
disclosed
determining whether
Prior art date
Application number
AT99968477T
Other languages
English (en)
Inventor
Gurjit K Khurana Hershey
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Application granted granted Critical
Publication of ATE307340T1 publication Critical patent/ATE307340T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5406IL-4
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • G01N2800/122Chronic or obstructive airway disorders, e.g. asthma COPD

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99968477T 1998-12-11 1999-12-10 Verfahren für die feststellung von asthma suszeptibilität ATE307340T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11193698P 1998-12-11 1998-12-11
PCT/US1999/029417 WO2000034789A2 (en) 1998-12-11 1999-12-10 Method for determining asthma susceptibility

Publications (1)

Publication Number Publication Date
ATE307340T1 true ATE307340T1 (de) 2005-11-15

Family

ID=22341233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968477T ATE307340T1 (de) 1998-12-11 1999-12-10 Verfahren für die feststellung von asthma suszeptibilität

Country Status (9)

Country Link
US (1) US6379890B1 (de)
EP (1) EP1137947B1 (de)
JP (1) JP2002532073A (de)
AT (1) ATE307340T1 (de)
AU (1) AU2588600A (de)
CA (1) CA2354673A1 (de)
DE (1) DE69927846T2 (de)
ES (1) ES2249061T3 (de)
WO (1) WO2000034789A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
WO2005032399A2 (en) * 2003-05-30 2005-04-14 The Regents Of The University Of California Il4 receptor antagonists for horse, dog and cat
US7732135B2 (en) 2003-08-05 2010-06-08 Hershey Gurjit K Khurana Genetic markers of food allergy
CA2597845A1 (en) 2005-02-25 2006-08-31 Isis Pharmaceuticals, Inc. Compositions and their uses directed to il-4r alpha
CA2624796A1 (en) * 2005-10-03 2007-04-12 Isis Pharmaceuticals, Inc. Combination therapy using budesonide and antisense oligonucleotide targeted to il-4 receptor alpha
EP1934375B1 (de) * 2005-10-13 2015-04-15 Hendrik Schulze-Koops Mittel und verfahren zur vorhersage von gelenkzerstörung
US7378717B2 (en) * 2005-11-15 2008-05-27 International Business Machines Corporation Semiconductor optical sensors
EP1969143A4 (de) * 2005-12-20 2009-07-22 Isis Pharmaceuticals Inc Auf il-4-rezeptor alpha als ziel gerichtete doppelsträngige nukleinsäuremoleküle
WO2008039716A2 (en) * 2006-09-28 2008-04-03 Centocor Ortho Biotech Inc. Method for detecting il-16 activity and modulation of il-16 activity based on phosphorylated stat-6 proxy levels
EP2141499A1 (de) * 2008-07-02 2010-01-06 Apoptec AG COPD-Diagnose
US20120088814A1 (en) 2009-03-31 2012-04-12 Isis Pharmaceuticals, Inc. Methods of modulating an immune response to a viral infection
EP3891179A4 (de) * 2018-12-04 2022-08-24 The Children's Medical Center Corporation Verfahren und zusammensetzungen zur behandlung von asthma
WO2021161997A1 (ja) * 2020-02-10 2021-08-19 国立大学法人山口大学 ヒトインターロイキン4受容体の変異ポリペプチド、及びm2マクロファージへの分化又は分極誘導剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654139A (en) * 1994-09-21 1997-08-05 The United States Of America As Represented By The Department Of Health And Human Services Allelic variation of the serotonin 5HT2c receptor
JPH11332567A (ja) * 1998-05-22 1999-12-07 Dai Ichi Seiyaku Co Ltd アトピー体質の判定方法

Also Published As

Publication number Publication date
CA2354673A1 (en) 2000-06-15
ES2249061T3 (es) 2006-03-16
WO2000034789A2 (en) 2000-06-15
US6379890B1 (en) 2002-04-30
DE69927846T2 (de) 2006-07-13
DE69927846D1 (de) 2006-03-02
JP2002532073A (ja) 2002-10-02
WO2000034789A3 (en) 2000-09-08
AU2588600A (en) 2000-06-26
EP1137947A2 (de) 2001-10-04
EP1137947B1 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
ATE307340T1 (de) Verfahren für die feststellung von asthma suszeptibilität
DE69925625D1 (de) Verfahren und vorrichtung zum vorhersagen von menschlichen kognitiven leistung
DE69920006D1 (de) Verfahren und vorrichtung für elektrochemische messungen unter verwendung von statistischen methoden
ES2164888T3 (es) Un metodo y un aparato para predecir la presencia de desequilibrios congenitos y adquiridos y estados terapeuticos.
ATE302976T1 (de) Anlage und verfahren zum vorhersagen von menschlichen kognitiven leistungen unter verwendung von aktigraphdaten
DE3575517D1 (de) Verfahren zur voraussage und feststellung des eintritts der ovulation.
DE69736669D1 (de) Zelladhäsionsinhibitoren
ATE402518T1 (de) Verfahren zum bestimmen eines numerischen wertes für die zeitliche dauer eines sich periodisch wiederholenden impulsförmigen signals, und vorrichtung zur durchführung eines solchen verfahrens
ATE447878T1 (de) Verfahren und vorrichtung zur augenverfolgung
DE69840008D1 (de) Verfahren und Vorrichtung für die Erzeugung von gestreuten Vektoren
DE69531077D1 (de) Verfahren und Vorrichtung mit Benutzereinwirkung der Art Erproben-und-Kaufen, die es ermöglicht, Software zu erproben
IT1208769B (it) Teristiche varianti nel tempo procedimento e dispositivo per la cancellazione numerica dell eco generato in collegamenti con carat
ATE514297T1 (de) Verfahren und system zur bereitstellung eines einzigen ruhestellungs-/messanforderungselements für vereinte kanäle in einem drahtlosen lokalen netzwerk gemäss 802.11
ATE268025T1 (de) Vorrichtung und verfahren für leistungs- und fehlerdatenanalyse
ATE404118T1 (de) System für kontinuierliche leistungstests
DE69621499D1 (de) Kalkulator zur Abschätzung der Maximalwahrscheinlichkeits-Abfolge und Verfahren hierfür
DE69523586D1 (de) Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
GB2349476A (en) Assessment of corrosion
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
DE60309453D1 (de) Vorrichtung zur verwaltung von einem patientenbehandlungsprogramm
DE69513027D1 (de) Verfahren zur bestimmung des präthrombotischen status
EP1117105A4 (de) Verfahren zur vorhersage des biegungsdauert von elektrische draht oder elektrische drahtbündel
ATE394360T1 (de) Verfahren zur verminderung von von der verwendung von fluorphosphitkatalysatoren herruehrenden fluoridverunreinigungen
ATE543429T1 (de) Verfahren zur bestimmung des sympathikus-tonus und messsystem dafür
EP0790059A4 (de) Vorrichtung zur behandlung von auto-immunkrankheiten und verfahren zur behandlung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137947

Country of ref document: EP

REN Ceased due to non-payment of the annual fee